Flexible Solutions International
NYSEAM:FSI Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 21 Fair Values set on narratives written by author
WA
Consensus Narrative from 1 Analyst
Investment In GLP-1 Drug Production Will Unlock New Profit Streams In 2025
Key Takeaways Strategic investments in GLP-1 drug compounding and new food products suggest significant future revenue potential in pharmaceuticals and nutraceuticals. Divestment and operational consolidation are expected to improve future earnings and net margins through efficiency gains.
View narrativeUS$9.00
FV
23.2% undervalued intrinsic discount27.32%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
8 days ago author updated this narrative